NCT05994768View on ClinicalTrials.gov

18F-FDG Tomography and Labeled Leukocyte Scintigraphy

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

December 18, 2020

Primary Completion Date

July 12, 2023

Study Completion Date

October 18, 2023

Conditions
Malignant Otitis Externa
Interventions
OTHER

18F-FDG PET/CT

Patients who underwent an 18F-FDG PET/CT examination and a labeled leukocyte scintigraphy before and after antibiotic therapy in the case of management of an EO.

Trial Locations (1)

54511

Verger Antoine, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT05994768 - 18F-FDG Tomography and Labeled Leukocyte Scintigraphy | Biotech Hunter | Biotech Hunter